<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01173237</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE 00160287000-10</org_study_id>
    <nct_id>NCT01173237</nct_id>
  </id_info>
  <brief_title>Efficacy Evaluation of Surfactant Administration Via Laryngeal Mask Airway</brief_title>
  <official_title>Efficacy Evaluation of Surfactant Administration for Respiratory Distress Syndrome Treatment Via Laryngeal Mask Airway. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the development of the Intubation Surfactant Extubation technic, in which surfactant is
      administered during a brief intubation followed by immediate extubation, surfactant therapy
      can be given during nasal continuous positive airway pressure treatment further reducing need
      for mechanical ventilation. Preterm newborn babies until eight hours of life, with
      respiratory distress syndrome, will be randomized to standard delivery of surfactant via
      endotracheal tube airway inserted after premedication for pain with midazolam and
      remifentanil or to surfactant delivery via Proseal laryngeal mask airway size 1. The intent
      is to is to compare efficacy and safety of surfactant administration via two different
      airways and ventilatory approaches.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fraction of inspired oxygen</measure>
    <time_frame>three hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hormonal evaluation of pain</measure>
    <time_frame>three hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proseal laryngeal mask surfactant treatment failure</measure>
    <time_frame>Six hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of respiratory distress syndrome complications</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <arm_group>
    <arm_group_label>Tracheal intubation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endotracheal tube is a airway device used for ventilation or surfactant administration, in preterm babies with SDR surfactant deficiency.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Proseal laryngeal mask airway</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laryngeal mask airway is a airway device used for ventilation with self-inflating bag or flow-inflating bag. In this study it will be used for surfactant administration, in preterm babies with SDR surfactant deficiency.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Use tracheal intubation for surfactant therapy</intervention_name>
    <description>Surfactant endotracheal administration after tracheal intubation</description>
    <arm_group_label>Tracheal intubation</arm_group_label>
    <other_name>Endotracheal tube</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Use of Proseal laryngeal mask airway for surfactant therapy</intervention_name>
    <description>Surfactant use by proseal laryngeal mask airway</description>
    <arm_group_label>Proseal laryngeal mask airway</arm_group_label>
    <other_name>Laryngeal mask airway</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Birthweight more than 1000 grams

          -  Gestational age more than 28 weeks and less than 35 weeks

          -  Chronologic age less than 8 hours

          -  Diagnosis of RDS by clinical and radiographic criteria

          -  Treated with nasal continuous positive airway pressure and supplemental oxygen more
             than 30%

          -  Parental consent

        Exclusion Criteria:

          -  Birthweight less than 1000 grams

          -  Gestational age more than 28 weeks and less than 35 weeks

          -  Chronologic age more than 8 hours

          -  Maternal fever or premature rupture of fetal membranes less than 18 hours

          -  Diagnosis other than respiratory distress syndrome

          -  Babies who require or have already had endotracheal intubation

          -  Analgesia and or sedation during the first six hours of life

          -  Apgar 5 minute score less than three

          -  Babies with congenital anomalies or signs of acute circulatory failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yerkes P Silva, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rosilu F Barbosa, MD, MSc</last_name>
    <phone>00 55 31 88144163</phone>
    <email>rosilu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maternidade Odete Valadares</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30110-072</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rosilu F Barbosa, MD, MSc</last_name>
      <phone>00 55 31 88144163</phone>
      <email>rosilu@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yerkes P Silva, MD, MSc, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Dia e Maternidade Unimed-BH</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30431-253</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rosilu F Barbosa, MD, MSc</last_name>
      <phone>00 55 31 88144163</phone>
      <email>rosilu@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yerkes P Silva, MD. MSc, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2010</study_first_submitted>
  <study_first_submitted_qc>July 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2010</study_first_posted>
  <last_update_submitted>June 27, 2011</last_update_submitted>
  <last_update_submitted_qc>June 27, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2011</last_update_posted>
  <responsible_party>
    <name_title>Rosilu Ferreira Barbosa</name_title>
    <organization>Federal University of Minas Gerais</organization>
  </responsible_party>
  <keyword>tracheal intubation</keyword>
  <keyword>proseal laryngeal mask airway</keyword>
  <keyword>neonate</keyword>
  <keyword>surfactant</keyword>
  <keyword>respiratory distress syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Surfactants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

